Press Releases

Nov 18, 2024 6:00am EST

Greenwich LifeSciences Provides Update on Corporate Events

Aug 01, 2024 6:00am EDT

Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain

Jun 26, 2024 7:33am EDT

Greenwich LifeSciences Set to Join Russell 2000 Index Again

Jun 14, 2024 6:00am EDT

Greenwich LifeSciences Announces $2.5 Million Private Placement

Mar 13, 2024 6:00am EDT

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

Mar 12, 2024 6:00am EDT

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

Feb 27, 2024 6:00am EST

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries

Feb 22, 2024 6:00am EST

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

Feb 14, 2024 6:00am EST

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

Nov 21, 2023 6:00am EST

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024